Live tape
Top 8, mentions 7d7,505META2,263 mentions▲ +0.06GOOGL1,504 mentions▲ +0.02NVDA797 mentions▲ +0.09MUSE665 mentions▲ +0.07MSFT602 mentions▲ +0.05SPY567 mentions▲ +0.05QQQ557 mentions▲ +0.08TSLA550 mentions▲ +0.06

Equity · Healthcare

CELC

Celcuity Inc. · NasdaqCM

$79.55 +0.15% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 25, 2026
Price · Chart
Our own end-of-day closes 62 sessions
$120 $60 30 Jun 25 Sep

The line runs $105 on 30 June through $79.55 on 25 September, on a scale from $60 to $120. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of CELC over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $105 on 30 June 2026 through $79.55 on 25 September 2026.

Market cap $3.9B
52-week range $45 – $145
Avg volume 52.9K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 25, 2026

CELC insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 14 Aug 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 3

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
14 Aug 2026 Sullivan Brian F. Chief Executive Officer Award 80,000
14 Aug 2026 Laing Lance G. Chief Science Officer Award 20,000
14 Aug 2026 Hahne Vicky Chief Financial Officer Award 16,000

CELC reported financials

SEC EDGAR XBRL

CELC reported net income of −$177.0M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$177.0M 31 Dec 2025 fiscal year
Diluted EPS −$3.79 31 Dec 2025 fiscal year
Total assets $828.2M 30 Jun 2026 at period end
Total equity −$12.8M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

CELC earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-1.44 —
31 Mar 2026 Q1 2026 $-0.97 —
31 Dec 2025 FY 2025 $-3.79 —
30 Sep 2025 Q3 2025 $-0.92 —
30 Jun 2025 Q2 2025 $-1.04 —
31 Mar 2025 Q1 2025 $-0.86 —
31 Dec 2024 FY 2024 $-2.83 —
30 Sep 2024 Q3 2024 $-0.70 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CELC institutional holders

SEC Form 13F

8 of the 45 institutional funds we track reported a CELC position for the quarter ended 30 Jun 2026 — a combined $929.1M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Baker Bros. Advisors Held (±25%) 7,915,792 $828.2M
Point72 Asset Management Added +132.2% shares 650,916 $68.1M
Marshall Wace Added +863.8% shares 182,156 $19.1M
Balyasny Asset Management Held (±25%) −10.4% shares 57,698 $6.0M
D. E. Shaw & Co. Added +46.7% shares 30,394 $3.2M
Man Group Trimmed −34.7% shares 28,845 $3.0M
AQR Capital Management Trimmed −29.2% shares 12,542 $1.3M
Fisher Asset Management New position 2,000 $209K
Citadel Advisors Exited
Millennium Management Exited

Source: SEC EDGAR 13F filings

CELC fails-to-deliver

SEC CNS data

On 25 Aug 2026, 4,328 shares of CELC failed to deliver (about $393K).

Settlement date Shares failed Notional % of shares out
25 Aug 2026 4,328 $393K 0.009%
19 Aug 2026 280 $26K 0.001%

Source: SEC fails-to-deliver (CNS) data